Mikron Machining Solutions

In the Machining Solutions business segment, the Mikron Machining division noted a continuation of the increased demand from the second half of 2021. This concerns the watch industry and the writing industry as well as new applications from the automotive industry outside of the combustion engine. Demand also increased in the service sector. Mikron Machining consolidated its activities into one building in Agno and further progressed its repositioning.

At Mikron Tool division, demand for its sophisticated cutting tools remained at a high level. Mikron Tool developed new products for applications in the pharmaceutical and medical technology industries to increase sales outside the automotive industry.

Key figures for Mikron Machining Solutions
At CHF 125.7 million, the Mikron Machining Solutions business segment exceeded net sales for the 2021 financial year (CHF 112.9 million) by 11.3%. Mikron Machining Solutions’ order intake rose to CHF 169.0 million (2021: CHF 135.4 million, +24.8%). The resulting order backlog of CHF 101.8 million at the end of 2022 was 66.6% higher than at the end of 2021 (CHF 61.1 million). Mikron Machining Solutions posted EBIT of CHF 9.3 million (2021: CHF 2.5 million) and an EBIT margin of 7.4% (2021: 2.2%).

50% of Mikron Machining Solutions’ sales came from Europe (2021: 50%), additional 15% from Switzerland (2021: 13%), 14% from North America (2021: 17%) and 20% from Asia (2021: 17%). The business segment achieved 24% of its net sales in the automotive industry, 18% in the consumer goods industry, 11% in the writing industry, and 9% in the industrial and building industries.

Innovations and continuous improvements
At the international exhibition for metalworking AMB 2022, Mikron Machining introduced the MultiX-C – a new development in the MultiX family – which allows the user to change batch for totally different parts in just a few minutes.

Mikron Tool further advanced its product development strategy and launched additional products especially for the medtech market.